联合使用阿那白滞素和巴瑞替尼治疗难治性成人斯蒂尔病。 - Suppr

Suppr

超能文献

Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy.

作者信息

Ladhari Chayma, Jorgensen Christian, Pers Yves-Marie

机构信息

Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital, France.

IRMB, INSERM, Université Montpellier, France.

出版信息

Rheumatology (Oxford). 2019 Apr 1;58(4):736-737. doi: 10.1093/rheumatology/key414.

DOI:10.1093/rheumatology/key414

PMID:30590753

Abstract

摘要

相似文献

Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy.

Rheumatology (Oxford). 2019 Apr 1;58(4):736-737. doi: 10.1093/rheumatology/key414.

Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.

Ann Rheum Dis. 2009 Mar;68(3):450-1. doi: 10.1136/ard.2008.093492.

Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra.

Int J Cardiol. 2014;172(1):e225-7. doi: 10.1016/j.ijcard.2013.12.151. Epub 2014 Jan 8.

Mixed results with baricitinib in biological-resistant adult-onset Still's disease and undifferentiated systemic autoinflammatory disease.

RMD Open. 2020 Jul;6(2). doi: 10.1136/rmdopen-2020-001246.

[Severe hepatitis in a patient with adult-onset Still's disease treated with anakinra].

Rev Med Interne. 2013 Mar;34(3):168-70. doi: 10.1016/j.revmed.2012.10.372. Epub 2012 Nov 20.

IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.

Ann Rheum Dis. 2010 Feb;69(2):466-7. doi: 10.1136/ard.2009.108068.

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study.

Arthritis Res Ther. 2011 Jun 17;13(3):R91. doi: 10.1186/ar3366.

Effective treatment of steroid refractory adult-onset Still's disease with anakinra.

J Rheumatol. 2008 May;35(5):939-41.

Refractory adult onset Still's disease successfully treated with anakinra.

Ann Rheum Dis. 2005 Apr;64(4):647-8. doi: 10.1136/ard.2004.026617. Epub 2004 Sep 16.

Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.

Rheumatology (Oxford). 2012 Sep;51(9):1730-2. doi: 10.1093/rheumatology/kes040. Epub 2012 Apr 17.

引用本文的文献

Successful management of Still's disease with severe liver injury through the administration of baricitinib: a case report.

Front Med (Lausanne). 2025 Jul 28;12:1591431. doi: 10.3389/fmed.2025.1591431. eCollection 2025.

Tofacitinib in the Treatment of Refractory Adult-Onset Still's Disease Co-diagnosed With Celiac Disease: A Case Report.

Cureus. 2025 May 25;17(5):e84770. doi: 10.7759/cureus.84770. eCollection 2025 May.

A Case Report of JAK Inhibitors Therapy for Adult-Onset Still's Disease with Persistent Pruritic Lesions.

Drugs R D. 2024 Sep;24(3):391-394. doi: 10.1007/s40268-024-00487-1. Epub 2024 Sep 18.

Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.

Mediterr J Rheumatol. 2024 Mar 30;35(Suppl 1):45-57. doi: 10.31138/mjr.290323.dat. eCollection 2024 Mar.

Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease.

Drugs R D. 2023 Jun;23(2):109-120. doi: 10.1007/s40268-023-00417-7. Epub 2023 Apr 3.

Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases.

J Inflamm Res. 2022 Oct 10;15:5739-5755. doi: 10.2147/JIR.S343261. eCollection 2022.

Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Front Med (Lausanne). 2022 Sep 16;9:989777. doi: 10.3389/fmed.2022.989777. eCollection 2022.

Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still's Disease.

Eur J Rheumatol. 2022 Oct;9(4):217-220. doi: 10.5152/eurjrheum.2022.21064.

Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review.

Front Med (Lausanne). 2022 Jun 27;9:930071. doi: 10.3389/fmed.2022.930071. eCollection 2022.

Progress in Biological Therapies for Adult-Onset Still's Disease.

Biologics. 2022 Apr 21;16:21-34. doi: 10.2147/BTT.S290329. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验